![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/366692493/figure/fig1/AS:11431281110218400@1672405353384/figure-fig1_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/359899890/figure/fig1/AS:1147734644011009@1650652671881/Properties-of-surface-modified-b-cyclodextrin-PPIs-A-Chemical-structure-of_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/358973874/figure/fig1/AS:1136650818199552@1648010081089/Identification-selection-and-validation-of-human-ACE2-specific-siRNAs-capable-to_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/359899890/figure/fig5/AS:1147734648209416@1650652672156/scFvAM1-P-BAP-guided-transposition-of-TP53-in-p53-deficient-PSCA-positive-tumor-cells_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/362874836/figure/fig1/AS:11431281080406265@1661287728019/Schematic-of-important-features-and-parameters-in-the-small-interfering-RNA-siRNA_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/366636201/figure/fig3/AS:11431281110053909@1672285756196/LPAR1-mediates-LPA-induced-FLNA-phosphorylation-and-MRTF-A-FLNA-complex-formation-A_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/358224212/figure/fig1/AS:1127625691017270@1645858323741/Schematic-illustration-o14PEGMA1125-NH3-CaP-NP-preparation-using-two-different_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/366636201/figure/fig5/AS:11431281110053910@1672285756394/Mapping-of-LPAR1-FLNA-interaction-sites-A-Immunoprecipitation-IP-in-HuH7-cells_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/358224212/figure/fig2/AS:1127625691021314@1645858323829/CaP-NP-number-distribution-for-different-PO-4-3-concentrations-in-the-presence-of-0-1_Q320.jpg)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
![Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile](https://www.researchgate.net/publication/362874836/figure/tbl1/AS:11431281080426509@1661287728109/siRNA-therapeutics-approved-for-clinical-use_Q320.jpg)